Stories

Alice Shaw, Global Head of Translational Clinical Oncology at Novartis, applies lessons from running clinical trials to the work of designing them.

Novartis is taming nuclear power and putting it to use to treat advanced cancer.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.

Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

Novartis researchers aim to quash inflammation to treat chronic disease.

Yan Zhao talks about how her team in China responded to an emerging public health crisis.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

Novartis CEO Vas Narasimhan answers questions about COVID-19.

Molecular glues are a new type of medicine inspired by nature’s matchmakers.

Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.